resveratrol has been researched along with jbp 485 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huo, X; Liu, K; Liu, Z; Ma, X; Meng, Q; Shu, R; Sun, H; Sun, P; Wang, C; Wu, J | 1 |
1 other study(ies) available for resveratrol and jbp 485
| Article | Year |
|---|---|
Resveratrol enhances the protective effects of JBP485 against indomethacin-induced rat intestinal damage in vivo and vitro through up-regulating oligopeptide transporter 1 (Pept1).
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Drug Synergism; Indomethacin; Intestinal Mucosa; Male; Peptide Transporter 1; Peptides, Cyclic; Rats; Rats, Wistar; Resveratrol; Up-Regulation | 2019 |